Article Text

PDF
Editorial
Quality of life of dogs with chronic epilepsy
  1. Chris Rundfeldt, DVM, Dr Med Vet Habil
  1. Drug Consulting Network, Coswig 01640, Germany and University of Veterinary Medicine Hannover, Hannover 30559, Germany, e-mail: chris.rundfeldt@t-online.de

Statistics from Altmetric.com

VETERINARIANS are faced with treating an ever-growing number of pets that have chronic diseases (A. Tipold, personal communication). This may be due to a change in perception of a companion animal's role. Pets are increasingly becoming members of the family deserving of a similar level of medical care that human family members receive. This development has led to a heightened need for defined treatment strategies for chronic diseases. The primary aim of medical treatment is to cure, but most chronic diseases are not curable (eg, idiopathic epilepsy). In life-threatening situations, such as status epilepticus, life-saving acute interventions that cause severe adverse drug reactions are deemed acceptable; however, in chronic treatment the focus is different.

Overall, the primary aim when treating idiopathic epilepsy must be to reduce disease signs (eg, seizure control) or at least significantly reduce monthly seizure frequency (Bhatti and others 2015). However, dogs undergoing chronic treatment often experience adverse drug reactions leaving the dog and its owner with the negative affects of the chronic disease clinical signs as well as adverse drug reactions.

In people the term quality of life (QOL), or, more specifically, health-related quality of life (HRQOL), describes the combined impact of the disease and the treatment and is often measured by using patient-reported outcomes …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.